NDC11 16110091530
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16110-0915-30 | 16110-0915 |
| 16110-915-30 | 16110-915 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TAZORAC | TAZAROTENE | Almirall, LLC | 021744d1-a6d7-4ad6-99c2-7187c24e64c6 | 2025-11-13 | Warnings, Adverse reactions | 16110-915-30 16110-915 16110091530 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.